首页> 外文期刊>Laboratory investigation >Microsatellite Analysis of Microdissected Tumor Cells and 6p High Density Microsatellite Analysis in Head and Neck Squamous Cell Carcinomas with Down-Regulated Human Leukocyte Antigen Class I Expression
【24h】

Microsatellite Analysis of Microdissected Tumor Cells and 6p High Density Microsatellite Analysis in Head and Neck Squamous Cell Carcinomas with Down-Regulated Human Leukocyte Antigen Class I Expression

机译:头颈部鳞状细胞癌中下调的人白细胞抗原I类表达的微解剖肿瘤细胞的微卫星分析和6p高密度微卫星分析

获取原文
       

摘要

Down-regulated human leukocyte antigen (HLA) class I expression is frequently correlated with allelic loss at 6p21.3, which is the location of the HLA coding sequence, in head and neck squamous cell carcinomas (HNSCCs). Previously, we have demonstrated loss of heterozygosity (LOH) at 6p21.3 for at least one locus in 49% of the HNSCCs using 5 microsatellite markers spanning the 4 megabase HLA region. In the present study, the detection threshold (25%) to assign LOH was addressed by laser-assisted microdissection of tumor cells from tumors containing marginal loss. In addition, we describe high density microsatellite analysis of chromosome 6p21.3 in HNSCC with down-regulated HLA class I expression. The purpose of this study was to refine the identification of genetic alterations at 6p21.3 and to pinpoint allelic loss to individual HLA class I genes, using additional markers closely located to the HLA-A, -B, and -C loci and the transporter associated with antigen processing (TAP) genes. LOH analysis by amplification of microsatellite markers and subsequent fluorescent detection is a rapid and sensitive technique to predict HLA class I loss phenotypes in tumors. LOH can be identified at 25% relative signal reduction. Analysis of heterogeneous tumor samples and samples containing a small amount of tumor cells is facilitated by laser-assisted microdissection of tumor cells. In addition, we showed that accurate HLA LOH analysis requires application of microsatellite markers in close proximity to HLA class I and TAP genes.
机译:在头颈部鳞状细胞癌(HNSCC)中,下调的人类白细胞抗原I类表达通常与6p21.3等位基因缺失相关,这是HLA编码序列的位置。以前,我们已经证明了使用跨越4兆碱基HLA区域的5个微卫星标记,至少有一个基因座在49%的HNSCC中在6p21.3处失去了杂合性(LOH)。在本研究中,通过激光辅助显微切割包含边缘缺失的肿瘤细胞来解决分配LOH的检测阈值(25%)。此外,我们描述了HNSCC I型表达下调的HNSCC中6p21.3号染色体的高密度微卫星分析。这项研究的目的是使用位于HLA-A,-B和-C位点附近的其他标记物和转运蛋白,完善6p21.3基因突变的鉴定,并查明单个HLA I类基因的等位基因缺失。与抗原加工(TAP)基因相关。通过扩增微卫星标志物并随后进行荧光检测进行的LOH分析是一种预测肿瘤中HLA I类丢失表型的快速灵敏的技术。 LOH可以在相对信号降低25%的情况下确定。激光辅助显微切割肿瘤细胞有助于异质性肿瘤样品和含有少量肿瘤细胞的样品的分析。此外,我们显示准确的HLA LOH分析需要在与HLA I类和TAP基因非常接近的地方应用微卫星标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号